Digitalising cell and gene therapies manufacturing: a case study

Lonza will be hosting a free webinar to discuss its innovative approach to digitalising the company’s cell and gene therapy manufacturing operations through the implementation of the MODA-ESTM Platform.

It will take place on 17 November.

In the webinar, Lonza will also outline future plans for utilising the platform to eliminate bottlenecks and achieve operational efficiency gains.

As cell therapy organisations increasingly seek to industrialise their manufacturing operations and scale up their capacity, moving away from paper batch records and digitalising their process becomes critical. To achieve more efficient, effective and flexible data capture, Lonza developed the MODA-ESTM Platform — a paperless batch record system that combines manufacturing and QC data to effectively meet the needs of cell and gene therapy manufacturing.

During the webinar Lonza, will discuss:

The IT challenges encountered in cell and gene therapy manufacturing, with an industry view from the BioPhorum IT Collaboration Group

 The supply challenges in cell and gene therapy manufacturing

 Updates on the Lonza Manufacturing Execution System project, including a project roadmap

Highlights from the MODA-ESTM Platform implementation and key factors for success

More information about attending the webinar is available at www.lonza.com/webinars

 

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free